- FDA approves combination of two GSK drugs for skin cancer
- 'Road to Healthy Skin' tour wraps up sixth year of free skin cancer screenings
- FDA approves Mekinist in combination with Tafinlar to treat patients with advanced melanoma
- Kathy Ireland's brand kiWW forms alliance to develop skin care devices
- P&G reformulates Olay Regenerist line
SKILLMAN, N.J. — The Skin Cancer Foundation's Road to Healthy Skin Tour, presented by Aveeno and Rite Aid, once again is touring the country to raise skin cancer awareness.
This year, the Aveeno brand is hitting the road in the tour's customized RV to make an estimated 85 stops in 27 states from March through September. It will provide free full-body skin cancer screenings, samples of Aveeno products and educational materials.
Since its start in 2008, the Road to Healthy Skin Tour, staffed with local volunteer dermatologists, has made approximately 330 stops, screening more than 13,000 people and detecting 239 suspected cases of melanoma.
Over the past 40 years, rates of melanoma in people aged 18 years to 39 years grew by 800% among women, and 400% among men. This year, an estimated 76,250 new cases of melanoma are projected to occur in the United States — up 6,020 cases from 2011 figures. Increased exposure to ultraviolet radiation is a key force driving this melanoma "epidemic," with indoor tanning among young women accounting for the disproportionate prevalence.
The Skin Cancer Foundation's Road to Healthy Skin Tour is an example of the work that the Aveeno team is looking to highlight through its new Be An Active Natural Fund, established in April to inspire people and organizations to embrace the spirit behind Active Naturals. Throughout the year, the makers of Aveeno will award more than $300,000 in grants to the Skin Cancer Foundation and individuals whose inspirational efforts nurture beautiful change in themselves, their communities and the world around them.